4.6 Review

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis

Surapon Nochaiwong et al.

Summary: This systematic review and meta-analysis found that the use of serotonin reuptake inhibitor (SRI) antidepressants in patients receiving antithrombotic therapy is associated with a higher risk of bleeding complications, including major bleeding, gastrointestinal bleeding, and any bleeding events. The risk is elevated among individuals receiving anticoagulants or antiplatelet therapy. Caution should be exercised in co-prescribing SRIs with antithrombotic therapy due to safety concerns regarding bleeding risks.

ANNALS OF MEDICINE (2022)

Article Dermatology

Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study

Jonas A. Adalsteinsson et al.

Summary: The study found that a cumulative dose of hydrochlorothiazide above 37,500 mg was associated with an increased risk of invasive SCC. Users of hydrochlorothiazide also had a higher risk of SCCis and BCC.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Article Dermatology

Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data

J. C. Kim et al.

Summary: This study revealed that cumulative use of HCTZ (>= 2500 mg) could increase the risk of NMSC in Koreans, especially the older age group. Thus, HCTZ could be a risk factor for NMSC in East Asian as well as white populations.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)

Review Dermatology

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color A Systematic Review

Fabiana C. P. S. Lopes et al.

Summary: The systematic review revealed a weak association between UV exposure and melanoma in skin of color, with most studies not supporting UV protection for melanoma prevention. However, the evidence quality is moderate to low, necessitating further research to fully elucidate this association.

JAMA DERMATOLOGY (2021)

Article Dermatology

Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group

R. Schneider et al.

Summary: Long-term use of HCTZ is associated with an increased risk of squamous cell carcinoma, while long-term use of indapamide is associated with an increased incidence of cutaneous malignant melanoma. Bendroflumethiazide may be a safer alternative for patients at increased risk of skin cancer.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Medicine, General & Internal

Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study

Aaron M. Drucker et al.

Summary: Higher cumulative exposure to thiazides was associated with increased rates of incident skin cancer in people aged 66 years and older, while there was no consistent evidence of association between other antihypertensive classes and keratinocyte carcinoma or melanoma.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Review Oncology

Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis

Seokyung An et al.

Summary: This study reviewed 54 studies and found that indoor tanning is associated with early-onset melanoma and NMSC, with higher risk in younger individuals. The findings emphasize the importance of avoiding indoor tanning in younger adults to reduce the risk of skin cancer.

CANCERS (2021)

Article Oncology

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

Emma Copland et al.

Summary: This study found no consistent evidence linking antihypertensive medication use to cancer risk, providing reassurance to clinical practice. However, evidence for some comparisons was insufficient to entirely rule out excess risk, particularly for calcium channel blockers.

LANCET ONCOLOGY (2021)

Article Public, Environmental & Occupational Health

Hydrochlorothiazide and risk of melanoma subtypes

Laurel A. Habel et al.

Summary: The study found an increased risk of lentigo subtype melanoma associated with high use of HCTZ, without evidence of a dose-response relationship, while the risk for other subtypes was not significant.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Oncology

The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study

Jing de Haan-Du et al.

Summary: In this study, long-term use of HCTZ in patients with diabetes was associated with an increased risk of cutaneous squamous cell carcinoma, while no similar risk increase was observed with thiazide-like diuretics.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Public, Environmental & Occupational Health

Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain

Luz M. Leon-Munoz et al.

Summary: Long-term and high cumulative use of HCTZ is associated with increased risk of keratinocyte carcinoma with a clear dose-response pattern in a European Mediterranean population. The association between HCTZ use and risk of malignant melanoma in this population was inconsistent.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Article Oncology

Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States

Efe Eworuke et al.

Summary: The study found that there was no significant difference in the risk of basal cell carcinoma between HCTZ and ACEI users in the US population, but there was an increased risk of squamous cell carcinoma associated with HCTZ use. Particularly among Caucasians, HCTZ users faced higher risks of both BCC and SCC.

JNCI CANCER SPECTRUM (2021)

Article Public, Environmental & Occupational Health

Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer

Julie Rouette et al.

Summary: Hydrochlorothiazide use is associated with an increased risk of cSCC, with evidence of a duration- and dose-response relationship; however, there is no association with an increased risk of BCC or melanoma.

DRUG SAFETY (2021)

Article Urology & Nephrology

Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients

Thibault Letellier et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Dermatology

Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study

Sidsel Arnspang Pedersen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Review Peripheral Vascular Disease

Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer

Reinhold Kreutz et al.

JOURNAL OF HYPERTENSION (2019)

Review Cardiac & Cardiovascular Systems

Do Thiazide Diuretics Increase the Risk of Skin Cancer? A Critical Review of the Scientific Evidence and Updated Meta-Analysis

Benedetta Bendinelli et al.

CURRENT CARDIOLOGY REPORTS (2019)

Review Pharmacology & Pharmacy

A review of the prescribing trend of thiazide-type and thiazide-like diuretics in hypertension: A UK perspective

Ryan J. McNally et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Dermatology

Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma

K. A. Su et al.

BRITISH JOURNAL OF DERMATOLOGY (2018)

Review Oncology

Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis

Sara Gandini et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)

Meeting Abstract Dermatology

Antihypertensive medications and risk of keratinocyte carcinoma

F. M. Shaw et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Article Dermatology

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Sidsel Arnspang Pedersen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Article Public, Environmental & Occupational Health

Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies

Huilin Tang et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)

Letter Medicine, General & Internal

Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

Anton Pottegard et al.

JAMA INTERNAL MEDICINE (2018)

Review Public, Environmental & Occupational Health

Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies

Huilin Tang et al.

DRUG SAFETY (2018)

Article Medicine, General & Internal

Hydrochlorothiazide use is strongly associated with risk of lip cancer

A. Pottegard et al.

JOURNAL OF INTERNAL MEDICINE (2017)

Article Mathematical & Computational Biology

Basics of meta-analysis: I2 is not an absolute measure of heterogeneity

Michael Borenstein et al.

RESEARCH SYNTHESIS METHODS (2017)

Article Medicine, General & Internal

Sensitivity Analysis in Observational Research: Introducing the E-Value

Tyler J. VanderWeele et al.

ANNALS OF INTERNAL MEDICINE (2017)

Article Public, Environmental & Occupational Health

Prevalence and Costs of Skin Cancer Treatment in the US, 2002-2006 and 2007-2011

Gery P. Guy et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)

Article Health Care Sciences & Services

Grading the strength of a body of evidence when assessing health care interventions: an EPC update

Nancy D. Berkman et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)

Article Dermatology

Use of antihypertensive drugs and risk of skin cancer

S. A. J. Schmidt et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Dermatology

Photosensitizing Agents and the Risk of Non-Melanoma Skin Cancer: A Population-Based Case-Control Study

Sarah N. Robinson et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Article Medicine, General & Internal

Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites

Gary D. Friedman et al.

ARCHIVES OF INTERNAL MEDICINE (2012)

Article Dermatology

Risk factors for actinic keratosis in eight European centres: a case-control study

A. Traianou et al.

BRITISH JOURNAL OF DERMATOLOGY (2012)

Article Health Care Sciences & Services

GRADE guidelines: 3. Rating the quality of evidence

Howard Balshem et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Medicine, General & Internal

Interpretation of random effects meta-analyses

Richard D. Riley et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Oncology

Photosensitizing Medication Use and Risk of Skin Cancer

Jeanette Kaae et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Statistics & Probability

How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies

Henian Chen et al.

COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2010)

Article Medicine, General & Internal

Outpatient hypertension treatment, treatment intensification, and control in western Europe and the United States

Y. Richard Wang et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)

Article Medicine, General & Internal

Meta-analysis of observational studies in epidemiology - A proposal for reporting

DF Stroup et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)